Experts will discuss the first oral disease-modifying drugs for MS. They will tell what is in development, how they work, side effects, and when they are expected on the market. Register now and they will contact you with details. If you have a question, ask it when you register.
For a little head start, visit Fingolimod and Me to see how the fingolimod clinical test is going from the viewpoint of an MSer participating in the trial.
technorati tags: mswebcast, oralmstherapy, fingolimod, downthemspath
